Morgan Stanley Sees Multiple Challenges Ahead for The Clorox Co.
February 05, 2014 at 09:34 AM EST
In a report published Wednesday, Morgan Stanley analyst Dara Mohsenian reiterated an Underweight rating and $85.00 price target on The Clorox Co. (NYSE: CLX ). In the report, Morgan Stanley noted, “We remain UW [on] CLX given we believe weak US consumer spending, heightened competition with incremental promotion, and Venezuela/Argentina